Barclays Sticks to Its Hold Rating for Smith & Nephew (SN)
In a report released yesterday, Hassan Al-Wakeel from Barclays maintained a Hold rating on Smith & Nephew. The company’s shares closed yesterday at p1,256.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Al-Wakeel covers the Healthcare sector, focusing on stocks such as Straumann Holding AG, Smith & Nephew, and Sonova Holding AG. According to TipRanks, Al-Wakeel has an average return of 0.1% and a 47.50% success rate on recommended stocks.
Currently, the analyst consensus on Smith & Nephew is a Moderate Buy with an average price target of p1,465.82, implying a 16.71% upside from current levels. In a report released on November 13, UBS also maintained a Hold rating on the stock with a p1,290.00 price target.
Based on Smith & Nephew’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of p2.99 billion and a net profit of p295.65 million. In comparison, last year the company earned a revenue of p2.83 billion and had a net profit of p214 million
Based on the recent corporate insider activity of 77 insiders, corporate insider sentiment is neutral on the stock.
Read More on GB:SN:
Disclaimer & DisclosureReport an Issue
- Smith & Nephew price target lowered to $34 from $36 at Canaccord
- Smith & Nephew price target raised to 1,563 GBp at Morgan Stanley
- Smith & Nephew Snats: Navigating Operational Hurdles Amid Mixed Performance
- Smith & Nephew, UFC announce multi-year extension of partnership
- Smith & Nephew price target raised to 1,700 GBp from 1,400 GBp at RBC Capital
